Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 2, 2009, Pages 207-212

  Liu, Hao ^a   Bai, Xiao Bin ^a   Shi, Song ^a   Cao, Yong Xiao ^b,c  

^a First Affiliated Hospital   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Antioxidant enzymes; Hydrogen sulfide; Intestinal ischaemia reperfusion

Indexed keywords

HYDROGEN SULFIDE; INTESTINE ENZYME; MALONALDEHYDE; PEROXIDASE; SODIUM DITHIONITE; SUPEROXIDE DISMUTASE; TETRAMETHYLPYRAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOPATHOLOGY; INTESTINE ISCHEMIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 59049106695     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.02.0010     Document Type: Article

References (34)

1. Hildebrand F, et al. Pathophysiologic changes and effects of hypothermia on outcome in elective surgery and trauma patients. Am J Surg 2004; 187: 363-371.
2. Mallick IH et al. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004; 49; 1359-1377.
3. Pierro A, Eaton S. Intestinal ischemia reperfusion injury and multisystem organ failure. Semin Pediatr Surg 2004; 13: 11-17.
4. Li L et al. Hydrogen sulphide: a novel mediator of inflammation? Curr Opin Pharmacol 2006; 6: 125-129.
5. 2S)? Br J Pharmacol 2006; 149: 609-610.
6. 2S) protects against regional myocardial ischemia-reperfusion injury: evidence for a role of K ATP channels. Basic Res Cardiol 2006; 101: 53-60.
7. Elrod JW et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007; 104: 15560-15565.
8. Rossoni G et al. The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. Br J Pharmacol 2007; 153: 100-109.
9. Zhu XQ et al. Protective effect and mechanism of tetramethyl- pyrazine on small intestinal ischemia reperfusion injury in rats. Shandong J Trad Chin Med 2002; 21: 490-492.
10. Chen Y, Shan JX. Experimental study of the protective effect of tetramethylpyrazine on rabbit intestinal ischemic reperfusion. Acad. J. Kaifeng Med Coll 2005; 24: 32-34.
11. Jin KK et al. Effects of ischemic preconditioning and Ligustrazine on the expression of P-selectin and ICAM-1 in remote organ after intestinal ischemia reperfusion in rats. J. Wenzhou Med Coll 2007; 37: 36-39.
12. Yang L, Zhao Y. Protective effect of tetramethylpyrazine on intestinal ischemia reperfusion injury in rats. Chin J Mod Drug Appl 2008; 2: 26-28.
13. Zhang CY et al. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 2003; 302: 810-816.
14. 2S protects myocardium against ischemia/ reperfusion injury and its effect on c-Fos protein expression in rats. Acta Physiol Sin 2008; 60: 221-227.
15. Kurtz CC et al. Hibernation confers resistance to intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2006; 291: G895-G901.
16. Kurose I et al. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 1994; 74: 376-382.
17. Cicalese L et al. Pyruvate prevents ischemia-reperfusion mucosal injury of rat small intestine. Am J Surg 1996; 171: 97-100; discussion 100-101.
18. Zhou JL et al. Role of nitric oxide and peroxynitrite anion in lung injury induced by intestinal ischemia-reperfusion in rats. World J Gastroenterol 2003; 9: 1318-1322.
19. Naito Y et al. Rosuvastatin reduces rat intestinal ischemia- reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein. World J Gastroenterol 2006; 12: 2024-2030.
20. Emre A et al. Sodium nitroprusside as a nitric oxide donor in a rat intestinal ischemia-reperfusion model. Clinics 2008; 63: 91-96.
21. Chiu CJ et al. Intestinal mucosal lesion in low-flow states. I A morphologic, hemodynamic and metabolic reappraisal. Arch Surg 1970; 101: 478.
22. Guneli E et al. Erythropoietin protects the intestine against ischemia/reperfusion injury in rats. Mol Med 2007; 13: 509-517.
23. Chen Y, Shan JX. Experimental study of the protective effect of tetramethylpyrazine on rabbit intestinal ischemic reperfusion. J Henan Univ (Med Sci) 2005; 24: 32-36.
24. Liu KX et al. Propofol attenuates intestinal mucosa injury induced by intestinal ischemia-reperfusion in the rat. Can J Anaesth 2007; 54: 366-374.
25. Wang XY et al. Effect of hydrogen sulfide on myocardial ischemia/reperfusion injury in isolated hearts of rats. Chin Pharmacol Bull 2006; 22: 1447-1451.
26. Distrutti E et al. Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J Pharmacol Exp Ther 2006; 316: 325-335.
27. Teague B et al. The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol 2002; 137: 139-145.
28. Li L, Moore PK. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci 2008; 29: 84-90.
29. Qu K et al. Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int 2008; 52: 155-165.
30. Fiorucci S et al. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 2006; 131: 259-271.
31. Carden DL, Granger DN. Pathophysiology of ischaemia- reperfusion injury. J Pathol 2000; 190: 255-266.
32. Gao C et al. Protective effects of hyperoxygenated solution preconditioning on intestinal ischemia-reperfusion injury in rabbits. J Surg Res 2006; 135: 268-274.
33. Leichtweis S, Ji LL. Glutathione deficiency intensifies ischaemia- reperfusion induced cardiac dysfunction and oxidative stress. Acta Physiol Scand 2001; 172: 1-10.
34. Pan TT et al. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol 2006; 40: 119-130.